← All Sponsors
SPONSOR

National Institute of Neurological Disorders and Stroke (NINDS)

Total Trials
9
Recruiting
9
Phases
Phase 2, EARLY_Phase 1, Phase 1, Phase 2

National Institute of Neurological Disorders and Stroke (NINDS) is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Progressive Multifocal Leukoencephalopathy, Fatigue Syndrome, Chronic, Tics, Functional Tics.

The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — National Institute of Neurological Disorders and Stroke (NINDS)

How many clinical trials has National Institute of Neurological Disorders and Stroke (NINDS) sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by National Institute of Neurological Disorders and Stroke (NINDS), of which 9 are actively recruiting participants. These trials cover conditions including Progressive Multifocal Leukoencephalopathy, Fatigue Syndrome, Chronic, Tics. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Institute of Neurological Disorders and Stroke (NINDS) research focus on?
National Institute of Neurological Disorders and Stroke (NINDS) clinical trials span Progressive Multifocal Leukoencephalopathy, Fatigue Syndrome, Chronic, Tics, Functional Tics, Amyotrophic Lateral Sclerosis Type 4, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Institute of Neurological Disorders and Stroke (NINDS) clinical trial?
To participate in a National Institute of Neurological Disorders and Stroke (NINDS) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Institute of Neurological Disorders and Stroke (NINDS) trials with current recruitment status updated daily.

Clinical Trials by National Institute of Neurological Disorders and Stroke (NINDS)

NCT07511049 Phase 2
Recruiting

Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study

Progressive Multifocal Leukoencephalopathy
NCT06472622 EARLY_Phase 1
Recruiting

Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort

Fatigue Syndrome, Chronic
NCT07137442
Recruiting

Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques

Tics
NCT04394871
Recruiting

Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing

Amyotrophic Lateral Sclerosis Type 4
NCT07416188 Phase 1, Phase 2
Recruiting

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Recurrent Glioblastoma
NCT04799288 Phase 1, Phase 2
Recruiting

Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis

HAM/TSP
NCT06203626
Recruiting

Ultra-Low Field (ULF) Point-of-Care (POC) MRI System for Brain Morphology and Pathology

Nervous System Diseases (C10 Unique ID D009422)
NCT05041387
Recruiting

Data Collection of Standard Care of Patients in the EMG Section

Neuropathy
NCT05375812
Recruiting

NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)

Gulf War Illness
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology